New directions with hormone therapy in prostate cancer: possible benefit from blocking prolactin and use of hormone treatment intermittently in combination with immunotherapy

Author： Oliver R.T.D.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.6, 1995-06, pp. : 859-860

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estramustine Phosphate Sodium: A Review of its Use in Combination Therapy for Hormone-Refractory Prostate Cancer

By Dene Simpson   Antona J. Wagstaff  

American Journal of Cancer, Vol. 2, Iss. 5, 2003-01 ,pp. : 373-390

Adis International

Access to resources Recommend Favorite

Hormone treatment for prostate cancer: current issues and future directions

By Ichikawa Tomohiko   Suzuki Hiroyoshi   Ueda Takeshi   Komiya Akira   Imamoto Takashi   Kojima Satoko  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 58-63

Springer Publishing Company

Access to resources Recommend Favorite

Fatigue in patients with prostate cancer receiving hormone therapy

By Stone P.   Hardy J.   Huddart R.   A'Hern R.   Richards M.  

European Journal of Cancer, Vol. 36, Iss. 9, 2000-06 ,pp. : 1134-1141

Elsevier

Access to resources Recommend Favorite

Hormone Resistance in Prostate Cancer

By Pilat M.J.P.  

Cancer and Metastasis Reviews, Vol. 17, Iss. 4, 1998-01 ,pp. : 373-381

Springer Publishing Company

Access to resources Recommend Favorite

The timing of hormone therapy for men with asymptomatic advanced prostate cancer

By Messing E.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 245-254

Elsevier

Access to resources Recommend Favorite